ESMO Breast 2024 | AI-enhanced mammogram screening for breast cancer risk assessment

Mikael Eriksson, PhD, Karolinska Institutet, Solna, Sweden, discusses using artificial intelligence (AI) tools in mammogram screenings to assess short-term and long-term cancer risk. The implementation of Cancer Forge by industry partners marks a significant translation of research into clinical practice, with ongoing clinical trials evaluating its effectiveness. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.